PharmAla Biotech & SABI Mind Announce MDMA Supply Agreement
Ryan Allway May 19th, 2022 Psychedelics, Top News PharmAla to supply SABI Mind’s Healing Centres, subject to Health Canada approval VANCOUVER, BC, May 19, 2022 /CNW/ – PharmAla Biotech (CSE: MDMA) is pleased to announce that it has signed an agreement with SABI Mind Inc. which will allow for its GMP... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )